Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Stichting European Clinical Research Alliance on Infectious Diseases

Research site

The Netherlands Archimedeslaan 6, 3584 BA Utrecht, The Netherlands

  • COVID-19 · Influenza
  • Adults and children

About Specializations

Stichting European Clinical Research Alliance on Infectious Diseases in Utrecht, The Netherlands specialises in clinical trials of conditions such as COVID-19, Influenza, and other specialisations. This site conducts important research.

Main research areas of the site

Virus Diseases

At Stichting European Clinical Research Alliance on Infectious Diseases in Utrecht, the clinical research focus is centered on virus diseases, with studies addressing major respiratory infections in adults. The trials are designed to evaluate how well preventive vaccines work and how safely they can be used in older populations.

  • Influenza virus prevention in adults aged 65 and older
  • Respiratory Syncytial Virus and its impact in adults 50 years and above
  • Assessment of vaccine effectiveness, immune response, and safety

The research includes efforts to compare influenza vaccines for protection against confirmed disease and to study whether an RSV vaccine can be used effectively alongside a COVID-19 mRNA vaccine, helping inform better vaccination strategies for respiratory infections.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Archimedeslaan 63584 BA UtrechtThe Netherlands
Open in maps ↗
Recruiting now
no trials
Conditions studied
2

More sites in UtrechtThe Netherlands

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Phase 2b Study of VXB-221 and VXB-213 Protein Vaccine for Prevention of Respiratory Syncytial Virus and Human Metapneumovirus Infections in Adults ≥60 Years

Not yet recruiting
Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Sponsor:Sanofi Pasteur Inc.

Influenza

Not recruiting

Study on the Effectiveness of an MF59-Adjuvanted Influenza Vaccine Compared to a Non-Adjuvanted Vaccine in Adults Aged 65 and Older

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:65+ years · Healthy volunteers
  • Substances:A/DARWIN/9/2021 (H3N2) - LIKE STRAIN (A/DARWIN/6/2021, IVR-227)
  • Sponsor:Seqirus UK Limited

Study on the Immune Response and Safety of RSVPreF3 OA Vaccine Alone and with COVID-19 mRNA Vaccine in Adults Aged 50 and Above

Not recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Raxtozinameran
  • Sponsor:GlaxoSmithKline Biologicals

COVID-19

Not recruiting

Study on the Effectiveness and Safety of Bemnifosbuvir for High-Risk COVID-19 Patients

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Nirmatrelvir
  • Sponsor:Atea Pharmaceuticals Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.